This evening, my colleagues and I published a paper in the New England Journal of Medicine that established that the FDA is approves drugs faster than its counterparts in Europe and Canada. Based on a careful review of applications for novel therapeutic agents approved from 2001 through 2010, we found that the FDA was almost ...